NPS Pharmaceuticals (NPSP) On Watch on Amgen (AMGN) Sensipar News
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $440.85 +0.62%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.3%
EPS Growth %: +2.7%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.3%
EPS Growth %: +2.7%
Join SI Premium – FREE
NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) is on watch on news the FDA has stopped all pediatric clinical trials of Amgen's (Nasdaq: AMGN) Sensipar after the recent death of a 14-year-old patient in a trial.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Yen Jumps More Than 1% To Trade At 158.22 Per Us Dollar
- Apple (AAPL) sets John Ternus' salary at $3M
- Amgen (AMGN) call put ratio 1 call to 1.1 puts
Create E-mail Alert Related Categories
Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
